| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/11/1998 | CA2272604A1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 06/11/1998 | CA2272548A1 Serine protease inhibitors |
| 06/11/1998 | CA2224334A1 Self-enhancing, pharmacologically controllable expression systems |
| 06/11/1998 | CA2224131A1 Novel human 11 cb splice variant |
| 06/10/1998 | EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae |
| 06/10/1998 | EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae |
| 06/10/1998 | EP0846765A1 Cell proliferation inhibitor |
| 06/10/1998 | EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family |
| 06/10/1998 | EP0846763A2 A protein phosphatase 1 binding protein, R5 |
| 06/10/1998 | EP0846762A2 Novel V31 seven transmembrane receptors |
| 06/10/1998 | EP0846761A1 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 06/10/1998 | EP0846760A1 Production and use of anthelmintic agents and protective immunogens |
| 06/10/1998 | EP0846701A1 Recombinant conglutinin and process for producing the same |
| 06/10/1998 | EP0846699A1 Substance wf16616, process for production thereof, and use thereof |
| 06/10/1998 | EP0846682A1 Penicillaminamide derivatives |
| 06/10/1998 | EP0846265A1 Methods for g protein coupled receptor activity screening |
| 06/10/1998 | EP0846178A1 Allergen-xcd32 fusion proteins |
| 06/10/1998 | EP0846176A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 06/10/1998 | EP0846174A1 Methods for enhancing the production of interferon in cell culture |
| 06/10/1998 | EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/10/1998 | EP0846172A2 Assay for identifying genes causing chromosome non-disjunction |
| 06/10/1998 | EP0846171A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 06/10/1998 | EP0846170A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 06/10/1998 | EP0846169A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES |
| 06/10/1998 | EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
| 06/10/1998 | EP0846160A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 06/10/1998 | EP0846128A2 Antimicrobial cationic peptides and methods of screening for the same |
| 06/10/1998 | EP0846127A1 Acylated oligopeptide derivatives having cell signal inhibiting activity |
| 06/10/1998 | EP0846125A2 INHIBITORS OF FACTOR Xa |
| 06/10/1998 | EP0846110A1 Thf-containing sulfonamide inhibitors of aspartyl protease |
| 06/10/1998 | EP0846001A1 Control of cd44 gene expression for therapeutic use |
| 06/10/1998 | EP0845998A1 Immunotherapy medicaments containing antibodies which specifically detect the mhcii antigen of a patient to be treated |
| 06/10/1998 | EP0845997A1 Stabile isotonic lyophilized protein formulation |
| 06/10/1998 | EP0845996A1 Treatment of nocturnal polyuria using an ace inhibitor in combination with a diuretic |
| 06/10/1998 | EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 06/10/1998 | EP0845994A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
| 06/10/1998 | EP0845993A1 Use of plasminogene activators to stimulate local bone growth |
| 06/10/1998 | EP0845992A1 Method of promoting angiogenesis |
| 06/10/1998 | EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 06/10/1998 | EP0845984A1 Use of aminoadamantane compounds as immunoregulators |
| 06/10/1998 | EP0845974A1 Compositions containing a peptide cell growth promoter |
| 06/10/1998 | EP0845963A1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 06/10/1998 | EP0845943A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 06/10/1998 | EP0845939A2 Lysosomal proteins produced in the milk of transgenic animals |
| 06/10/1998 | EP0759069A4 Beta taipoxin as a cell growth factor and method |
| 06/10/1998 | EP0748190A4 Methods and formulations for use in treating benign gynecological disorders |
| 06/10/1998 | EP0733106A4 Plant arabinogalactan protein (agp) genes |
| 06/10/1998 | EP0721346B1 Methods for inducing antigen-specific t cell tolerance |
| 06/10/1998 | EP0629210B1 Peptide linkage unit comprising methylene phosphinic acid |
| 06/10/1998 | EP0487627B1 Wound healing preparations containing heparanase |
| 06/10/1998 | EP0309569B1 Production of purified, biologically active, bacterially produced recombinant human csf-1 |
| 06/10/1998 | DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation |
| 06/10/1998 | DE19650142A1 nCL-3, a truncated calpain |
| 06/10/1998 | CN1184506A DNA molecule relating to suppression of gene expression and novel protein |
| 06/10/1998 | CN1184484A Novel anti-AIDS immunotoxins |
| 06/10/1998 | CN1184483A Fucopeptides |
| 06/10/1998 | CN1184472A Reversible protease inhibitors |
| 06/10/1998 | CN1184430A Compositions of interleukin and pyrimidine nucleosides |
| 06/10/1998 | CN1184420A Production scale method of forming microparticles |
| 06/10/1998 | CN1184254A Modulation of LC132 (opioid -like) receptor function |
| 06/10/1998 | CN1184112A Inositolglycans having insulin-like action |
| 06/10/1998 | CN1183989A Buffering liquid for staphylococcus Aureus Injection and stephylococcus Aureus Injection with buffering liquid |
| 06/10/1998 | CN1183963A Protein invertase injection |
| 06/10/1998 | CN1183910A 口香糖 Chewing gum |
| 06/09/1998 | US5763739 Genetic engineering |
| 06/09/1998 | US5763733 Antigen-binding fusion proteins |
| 06/09/1998 | US5763631 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof |
| 06/09/1998 | US5763604 Anticoagulants |
| 06/09/1998 | US5763591 Use for screening insulin-dependent diabetes mellitus disease |
| 06/09/1998 | US5763584 Receptor activation with hepatocyte growth factor agonists |
| 06/09/1998 | US5763580 A polypeptide analogs of hgpiib c-terminal fragment, useful for diagnosis of blood clotting and thrombi |
| 06/09/1998 | US5763577 Anticarcinogenic agents |
| 06/09/1998 | US5763576 Tetrapeptide α-ketoamides |
| 06/09/1998 | US5763575 Agonist and antagonist peptides of the C140 receptor |
| 06/09/1998 | US5763573 GTPase activating protein fragments |
| 06/09/1998 | US5763572 HTLV-II peptide antigens |
| 06/09/1998 | US5763571 Amino acid sequences which inhibit binding |
| 06/09/1998 | US5763570 Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/09/1998 | US5763569 Polypeptides as calcium receptors to generate antibodies |
| 06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
| 06/09/1998 | US5763566 Systematic evolution of ligands by exponential enrichment: tissue SELEX |
| 06/09/1998 | US5763484 Metabolites of linoleic acid and a-linolenic acid |
| 06/09/1998 | US5763472 Detection of microbes in water with kits having proteins |
| 06/09/1998 | US5763441 Administering to the patient suffering from diabetes, glioma, hemangioma, kaposi's sarcoma, ovarian/breast/pancreatic/colon and prostate cancer a benzo(g)quinoxaline compounds |
| 06/09/1998 | US5763429 Method of treating prostatic diseases using active vitamin D analogues |
| 06/09/1998 | US5763416 Stimulating bone repair and regeneration |
| 06/09/1998 | US5763415 Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
| 06/09/1998 | US5763411 Solid support coated with fibrin monomer readily capable of being converted to fibrin polymer sealant or hemostat |
| 06/09/1998 | US5763410 Kit for preparing a fibrin sealant |
| 06/09/1998 | US5763409 Stable freeze-dried formulation comprising a protein assay kit |
| 06/09/1998 | US5763408 Tumor metastasis inhibitors |
| 06/09/1998 | US5763407 Cyclic peptides as antidiabetic agents |
| 06/09/1998 | US5763406 Method for the treatment of conditions caused by herpes virus infections |
| 06/09/1998 | US5763405 Stabilized composition for oral administration of peptides |
| 06/09/1998 | US5763404 Methods for using LHRH antagonists with low histamine release |
| 06/09/1998 | US5763403 Poisons, proteins with amino acid sequences |
| 06/09/1998 | US5763402 Administering pacap (pituitary adenylate cyclase activating polypeptide), pacap agonist, pc4 or pc4 agonist |
| 06/09/1998 | US5763401 Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
| 06/09/1998 | US5763400 Controlling insects |
| 06/09/1998 | US5763399 Revitalizing tissues with growth factor |